Search Results

Displaying Results 1751-1775 of 2267 "'GB'"

Dec 04, 2025, 10:42 ET SPhotonix Secures $4.5 Million Pre-Seed Investment to Pioneer the Future of 5D Optical Memory and Optics

Prof. Peter Kazansky, who developed the technology over the last twenty years, revealed how he had preserved the human genome (15 GB) for billions of years, in a 5D Memory Crystal and recently stored the entire Wikipedia, perceived to be the carrier of all human knowledge in a small

More news about: SPhotonix


Dec 04, 2025, 10:34 ET Global Demand for Bio-Fermented Hyaluronic Acid to Triple by 2035 - FMI Forecast

team - https://www.futuremarketinsights.com/reports/sample/rep-gb-29325 For Yearly Reports Subscription Please Contact us here  -

More news about: Future Market Insights, Inc.


Dec 04, 2025, 09:00 ET Mitrade CFD Broker Caps 2025 com nova licença, acesso expandido ao mercado e recorde de 16 prêmios em meio a uma expansão de 20% em sua base de usuários

e reconhecida mundialmente, licenciada sob a FSCA da África do Sul (FSP 54842), a CIMA das Ilhas Cayman (SIB1612446), a FSC das Ilhas Maurício (GB20025791), a ASIC da Austrália (AFSL398528) e a CySEC do Chipre (CIF438/23).Conectando mais de 6 milhões de traders a mais de 800 derivativos OTC, incluindo

More news about: Mitrade Group


Dec 04, 2025, 09:00 ET Mitrade, el bróker de CFD, cierra 2025 con una nueva licencia, un mayor acceso al mercado y un récord de 16 premios, en medio de un crecimiento del 20 % en su base de usuarios

mundial y galardonada, que cuenta con licencia de la FSCA de Sudáfrica (FSP 54842), la CIMA de las Islas Caimán (SIB1612446), la FSC de Mauricio (GB20025791), la ASIC de Australia (AFSL398528) y la CySEC de Chipre (CIF438/23).La plataforma de Mitrade conecta a más de 6 millones de operadores con

More news about: Mitrade Group


Dec 04, 2025, 01:00 ET Mitrade CFD Broker Caps 2025 With New Licence, Expanded Market Access and Record 16 Awards Amid a 20% Expansion in Its User Base

recognised, award-winning CFD trading platform licensed under South Africa's FSCA (FSP 54842), Cayman Islands' CIMA (SIB1612446), Mauritius's FSC (GB20025791), Australia's ASIC (AFSL398528), and Cyprus's CySEC (CIF438/23).Connecting 6M+ traders to 800+ OTC derivatives, including indices, forex, commodities,

More news about: Mitrade Group


Dec 03, 2025, 21:21 ET Infortrend High-Density 90-Bay Storage Helps Tackle Data Growth and Rack Constraints in Diverse Enterprise Deployments

proven highly effective in a wider range of enterprise environments where data demands continue to grow. EonStor GS 90-bay solution delivers up to 45 GB/s throughput and 2PB raw capacity in a 4U footprint. Featuring dual-redundant controllers, GS ensures continuous operation and data protection. It supports

More news about: Infortrend Technology


Dec 03, 2025, 15:27 ET Global AI and HUMAIN Partner to Accelerate Sovereign AI with Large-Scale NVIDIA-Powered AI Centers

AI's position as the world's leading provider of sovereign AI infrastructureNVIDIA Cloud Partner Global AI receives first shipment of NVIDIA GB300 NVL72 systemsat its New York data center, reinforcing rapid U.S. deployment momentumWASHINGTON,

More news about: Global AI


Dec 03, 2025, 12:50 ET Natural Food Colors Market Set to Grow to USD 4.03 B by 2035, Creating a Global Standard-Bearer for Clean-Label Ingredients

Here -  https://www.futuremarketinsights.com/reports/brochure/rep-gb-35 For Yearly Reports Subscription Please Contact us here -

More news about: Future Market Insights


Dec 03, 2025, 09:05 ET FMI Reports Strong 11.7% CAGR Growth Outlook for the GLP-1 Receptor Agonist Market Through 2035

https://www.futuremarketinsights.com/reports/sample/rep-gb-12346 Recent Innovations and Market-Shaping DevelopmentsJune 24, 2025: Eli

More news about: Future Market Insights, Inc.


Dec 03, 2025, 04:19 ET GEEKOM Expands Into Middle East Market With Premium Mini PCs

devices designed to meet the needs of professionals, creators, and everyday users alike. The GEEKOM A5, equipped with the AMD Ryzen 5 7430U processor and 16GB of DDR4 RAM, is tailored for students, office workers, and everyday computing tasks, delivering smooth performance in a highly portable design. The GEEKOM

More news about: GEEKOM


Dec 03, 2025, 04:13 ET Infortrend High-Density 90-Bay Storage Helps Tackle Data Growth and Rack Constraints in Diverse Enterprise Deployments

proven highly effective in a wider range of enterprise environments where data demands continue to grow. EonStor GS 90-bay solution delivers up to 45 GB/s throughput and 2PB raw capacity in a 4U footprint. Featuring dual-redundant controllers, GS ensures continuous operation and data protection. It supports

More news about: Infortrend Technology


Dec 03, 2025, 03:13 ET 90-Bay-Storage von Infortrend sorgt für optimale Rack-Auslastung in verschiedensten Enterprise-Umgebungen

Unternehmensumgebungen, in denen der Datenbedarf kontinuierlich wächst, als äußerst effektiv erwiesen. Die EonStor GS 90-Bay-Lösung bietet einen Durchsatz von bis zu 45 GB/s und eine Rohkapazität von 2 PB bei einer Stellfläche von 4 HE. Mit doppelt redundanten Controllern gewährleistet GS einen kontinuierlichen Betrieb

More news about: Infortrend Technology


Dec 03, 2025, 03:13 ET El almacenamiento de alta densidad de 90 bahías de Infortrend ayuda a afrontar el crecimiento de datos

amplia gama de entornos empresariales donde la demanda de datos sigue creciendo. La solución EonStor GS de 90 bahías ofrece un rendimiento de hasta 45 GB/s y 2 PB de capacidad bruta en un espacio de 4U. Con controladores de doble redundancia, GS garantiza un funcionamiento continuo y la protección de datos.

More news about: Infortrend Technology


Dec 03, 2025, 01:13 ET Infortrend Yüksek Yoğunluklu 90 Bölmeli Depolama, Çeşitli Kurumsal Dağıtımlarda Veri Büyümesi ve Raf Kısıtlamalarının Üstesinden Gelmeye Yardımcı Oluyor

devam ettiği daha geniş bir kurumsal ortam yelpazesinde oldukça etkili olduğunu kanıtlamıştır. EonStor GS 90 yuvalı çözüm, 4U boyutunda bir alanda 45 GB/s'ye kadar çıkış ve 2PB ham kapasite sunar. Çift yedekli kontrolörlere sahip olan GS, kesintisiz çalışma ve veri koruması sağlıyor. Dosya, blok ve nesne

More news about: Infortrend Technology


Dec 02, 2025, 10:30 ET Sparklight Launches Sparklight Mobile, Expanding Affordable Connectivity Beyond the Home

existing mobile number and choose from three affordable plans when bundled with Sparklight home internet:1 GB data for $15/month5 GB data for $25/monthUnlimited data for $30/monthA Natural Extension of Sparklight's Connectivity

More news about: Sparklight


Dec 02, 2025, 10:00 ET Cytrence Introduces Kiwi+: A New Generation of Kiwi KVM Tools for Engineering and IT Professionals

installationFlexible and secure network communicationsKiwi+ Drive: All-in-One KVM with Built-in StorageKiwi+ Drive integrates a built-in 32GB storage module, enabling users to copy files, perform recovery tasks, and even boot or install OS directly from the built-in drive. Tasks that once required

More news about: Cytrence Technologies, Inc.


Dec 01, 2025, 15:54 ET Yooz round table - Global e-invoicing & compliance: Roadmap and insights for CFOs

they present for your organisation!About Yooz - https://www.getyooz.com/en-gb/Yooz provides the smartest, most powerful and easiest-to-use cloud-based E-invoicing and Purchase-to-Pay (P2P) automation solution.

More news about: Yooz


Dec 01, 2025, 11:21 ET Generate:Biomedicines lance des essais mondiaux de phase 3 sur le GB-0895, un anticorps anti-TSLP à longue durée d'action pour le traitement de l'asthme sévère, conçu grâce à l'IA

www.solairia.com.À propos du GB-0895Le GB-0895 a été conçu avec la plateforme de biologie générative de Generate, qui intègre des modèles propriétaires d'apprentissage automatique à l'expérimentation à haut débit. Le GB-0895 a été conçu pour bloquer la TSLP, une cytokine

More news about: Generate:Biomedicines


Dec 01, 2025, 10:46 ET Generate:Biomedicines rozpoczyna globalne badania III fazy nad GB-0895, przeciwciałem o długim działaniu skierowanym przeciwko limfopoetynie zrębu grasicy (TSLP) przeznaczonym do leczenia astmy ciężkiej, opracowanym przy użyciu sztucznej inteligencji

www.solairia.com.Przeciwciało GB-0895 Przeciwciało GB-0895 zostało opracowane przy użyciu platformy biologii generatywnej firmy Generate, integrującej autorskie modele uczenia maszynowego z eksperymentami o wysokiej wydajności. Przeciwciało GB-0895 ma na celu blokowanie TSLP, cytokiny

More news about: Generate:Biomedicines


Dec 01, 2025, 06:00 ET Generate:Biomedicines 將啟動 GB-0895 全球三期臨床試驗,此為運用人工智能科技研發的長效抗 TSLP 抗體,專治嚴重哮喘

Generate)今天宣佈,計劃啟動兩項全球性第三期臨床試驗 —— SOLAIRIA-1 與 SOLAIRIA-2,旨在評估 GB-0895 對約 1,600 名成人及青少年嚴重哮喘病人的療效。這些病人目前接受現行療法後,病情仍未獲得充分控制。GB-0895 是一種實驗性長效單株抗體,經人工智能工程改造後,專門針對胸腺基質淋巴細胞生成素 (thymic stromal lymphopoietin; TSLP) —— 此物質是氣道炎症的關鍵驅動因子。這些研究將評估 GB-0895 在 52 星期內降低臨床顯著性哮喘急性發作的療效,此為兩項試驗的主要目標。

More news about: Generate:Biomedicines


Dec 01, 2025, 06:00 ET Generate:Biomedicines、AI技術で設計した長時間作用型抗TSLP抗体「GB-0895」による重症喘息対象のグローバル第3相試験を開始へ

SOLAIRIA-1およびSOLAIRIA-2は、現在の治療で十分な疾患コントロールが得られていない重症喘息患者約1,600名を対象に、GB-0895の有効性を評価する長時間作用型抗TSLP抗体として世界初のグローバル第3相試験であり、GB-0895がプログラム可能な生物学の可能性を現実のものとする上で重要な一歩となるサマービル(マサチューセッツ州)、2025年12月1日 /PRNewswire/

More news about: Generate:Biomedicines


Dec 01, 2025, 06:00 ET Generate:Biomedicines Memulai Penelitian Fase 3 Global Tentang GB-0895, Antibodi Anti-TSLP Kerja Lambat yang Direkayasa AI Untuk Asma Berat

SOLAIRIA-1 dan SOLAIRIA-2, untuk mengevaluasi GB-0895 pada sekitar 1.600 penderita asma berat usia dewasa dan remaja yang penyakitnya masih kurang terkendali meskipun sedang menjalani terapi. GB-0895 adalah antibodi monoklonal kerja lambat yang masih dalam penyelidikan. GB-0895 direkayasa AI untuk menargetkan

More news about: Generate:Biomedicines


Dec 01, 2025, 06:00 ET Generate:Biomedicines spúšťa globálne štúdie 3. fázy liečiva GB-0895 - anti-TSLP protilátky s dlhým pôsobením na liečbu ťažkej astmy, vyvinutej pomocou AI

www.solairia.com.O lieku GB-0895GB-0895 bol navrhnutý s využitím platformy generatívnej biológie Generate, ktorá integruje vlastné modely strojového učenia s vysokovýkonnými experimentmi. GB-0895 bol vyvinutý tak, aby blokoval TSLP, cytokín odvodený z

More news about: Generate:Biomedicines


Dec 01, 2025, 06:00 ET Generate:Biomedicines начинает 3 фазу глобальных клинических испытаний разработанного с использованием ИИ препарата GB-0895 -- антитела длительного действия, направленного на блокировку TSLP при тяжелых случаях астмы

www.solairia.com.О GB-0895GB-0895 был разработан с помощью платформы генеративной биологии Generate, которая объединяет запатентованные модели машинного обучения с высокопроизводительными экспериментами. GB-0895 был спроектирован для блокировки TSLP, цитокина,

More news about: Generate:Biomedicines


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.